79.47

3.25% 2.50

Pre-market: 79.50 0.03 +0.04%

Genedx Holdings Corp (WGS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Genedx Holdings Corp stock is traded at $79.47, with a volume of 689.95K. It is up +3.25% in the last 24 hours and down -6.89% over the past month. GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Previous Close:

$76.97

Open:

$77.09

24h Volume:

689.95K

Relative Volume:

1.09

Market Cap:

$2.33B

Revenue:

$267.23M

Net Income/Loss:

$-83.50M

P/E Ratio:

-25.55

EPS:

-3.11

Net Cash Flow:

$-59.99M

1W Performance:

+0.72%

1M Performance:

-6.89%

6M Performance:

-38.99%

1Y Performance:

-19.73%

1-Day Range:

$76.74

$79.83

1-Week Range:

$68.55

$82.83

52-Week Range:

$55.17

$170.87

Genedx Holdings Corp Stock (WGS) Company Profile

Name

Genedx Holdings Corp

Sector

Healthcare (1106)

Industry

Diagnostics & Research (52)

Phone

888-729-1206

Address

333 LUDLOW STREET, STAMFORD

Employee

1,300

Twitter

Next Earnings Date

2025-02-18

Latest SEC Filings

WGS's Discussions on Twitter

Compare WGS vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WGS Genedx Holdings Corp	79.47	2.25B	267.23M	-83.50M	-59.99M	-3.11
TMO Thermo Fisher Scientific Inc	512.69	190.90B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	204.73	144.26B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	648.70	50.60B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	120.54	33.67B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	319.04	30.62B	3.17B	642.63M	516.49M	10.77

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-20-25	Initiated	Canaccord Genuity	Buy
Jul-09-25	Initiated	Piper Sandler	Overweight
May-15-25	Initiated	Guggenheim	Buy
May-09-25	Upgrade	Jefferies	Hold → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jul-10-24	Initiated	Craig Hallum	Buy
Jun-03-24	Resumed	Jefferies	Hold

View All

Genedx Holdings Corp Stock (WGS) Latest News

03:38 AM

ARK Investment Management LLC Purchases New Stake in GeneDx Holdings Corp. $WGS - MarketBeat

03:38 AM

03:36 AM

Amova Asset Management Americas Inc. Invests $31.44 Million in GeneDx Holdings Corp. $WGS - MarketBeat

03:36 AM

12:53 PM

New Blackstone Loan And Refinancing Might Change The Case For Investing In GeneDx Holdings (WGS) - simplywall.st

12:53 PM

Mar 04, 2026

Down 25% in 4 Weeks, Here's Why GENEDX HOLDINGS (WGS) Looks Ripe for a Turnaround - Finviz

Mar 03, 2026

Down 25% Over the Past Month, Here’s Why GENEDX HOLDINGS (WGS) May Be Poised for a Rebound - Bitget

Mar 03, 2026

Mar 02, 2026

GeneDx (NASDAQ:WGS) Trading Down 6.6%Should You Sell? - MarketBeat

Mar 02, 2026

GeneDx Secures New $100 Million Term Loan Facility - TipRanks

Mar 02, 2026

GeneDx Secures $100 Million Five-Year Term Loan From Blackstone to Refinance Debt - TradingView

Mar 02, 2026

GeneDx (NASDAQ: WGS) adds $100M secured term loan from Blackstone lenders - Stock Titan

Mar 02, 2026

Macro Review: Can GeneDx Holdings Corp Equity Warrant stock outperform in a bear marketJuly 2025 PreEarnings & Fast Gain Stock Trading Tips - baoquankhu1.vn

Mar 02, 2026

Mar 01, 2026

GeneDx Insider Sale And Legal Review Contrast With FDA Breakthrough Upside - Yahoo Finance

Mar 01, 2026